Streetbeat News

Analyst Ratings

EQIX

Significant bearish positions have been taken in Equinix (NASDAQ:EQIX) by investors, as revealed by Benzinga's options scanner. The scanner identified 8 unusual options transactions, with a bearish sentiment prevailing (62% bearish, 37% bullish). The transactions include 7 puts valued at $1,741,480 and a single call worth $32,500, targeting a price range of $860.0 to $910.0 for EQIX. Equinix operates 260 data centers globally and serves over 10,000 customers. The stock's current price is $893.56, with an RSI indicating it may be approaching overbought territory. Analyst ratings in the last month have varied, with an average target price of $714.4.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 4:30 pm

CAVA

Deep-pocketed investors have shown a bearish sentiment towards Cava Group (NYSE:CAVA), with options trading indicating a divided mood but leaning more towards bearish with 58% against 41% bullish. The options market activity suggests targeting a price range of $45.0 to $75.0 for CAVA over the last 3 months. Current trading volume is 1,159,242 with a slight increase in price by 0.43%, now at $63.05. Analysts have varying opinions with an average target price of $60.0, with ratings ranging from Neutral to Overweight.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 4:30 pm

LOW

Loop Capital analyst Laura Champine maintains a Hold rating on Lowe's Companies (NYSE:LOW) and raises the price target from $220 to $225.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 4:28 pm

NIO

HSBC analyst Yuqian Ding maintains a Buy rating on NIO Inc. (NYSE:NIO) but lowers the price target from $10.2 to $7.9.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 4:24 pm

ANAB

AnaptysBio's stock price increased following an upgrade from Neutral to Outperform by Wedbush.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 4:19 pm

IR

Analyst Andrew Buscaglia initiates coverage on Ingersoll Rand (NYSE:IR) with a Neutral rating and sets a price target of $92.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 4:19 pm

DRTS

HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Alpha Tau Medical (NASDAQ:DRTS) and maintained a $9 price target.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 4:19 pm

PNR

Exane BNP Paribas analyst Andrew Buscaglia initiates coverage on Pentair (PNR) with a Neutral rating and a price target of $86.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 4:17 pm

XYL

Exane BNP Paribas analyst Andrew Buscaglia initiates coverage on Xylem (NYSE:XYL) with an Outperform rating and a price target of $150.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 4:16 pm

ZWS

Exane BNP Paribas analyst Andrew Buscaglia initiates coverage on Zurn Elkay Water (ZWS) with an Outperform rating and a price target of $40.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 4:14 pm